| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $59.9M | — | +79.1% |
| SG&A Expense | $19.9M | — | +61.2% |
| Operating Income | -$79.8M | — | -159.2% |
| Pre-tax Income | -$78.4M | — | -216.9% |
| Income Tax | $850K | — | -39.2% |
| Net Income | -$79.2M | — | -203.2% |
| EPS (Basic) | -$0.52 | — | -160.0% |
| EPS (Diluted) | -$0.52 | — | -160.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $62.4M | +1.8% | -40.6% |
| Short-term Investments | $214.2M | -8.2% | +19.4% |
| Current Assets | $348.7M | -5.2% | +0.3% |
| Total Assets | $641.8M | -6.7% | +21.6% |
| Current Liabilities | $36.6M | -14.8% | +51.1% |
| Long-term Debt | $110.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$72.2M | — | -26.2% |
| Investing Cash Flow | $42.7M | — | +119.2% |
| Financing Cash Flow | $30.5M | — | +887.3% |
| +1.1% |
| Total Liabilities | $154.4M | -3.9% | +9.1% |
| Stockholders' Equity | $487.3M | -7.5% | +26.2% |